The U.S. Food and Drug Administration (FDA) has recently given its approval for two groundbreaking treatments, Lyfgenia and Casgevy, offering new hope to patients with sickle cell disease. Lyfgenia and Casgevy represent a significant leap in treating sickle cell disease, a hereditary blood disorder affecting around 100,000 Americans. Lyfgenia, developed by Bluebird Bio, employs gene-editing techniques to eliminate pain crises associated with the condition. Casgevy, … Continue reading FDA Approves Breakthrough Gene Therapies for Sickle Cell Disease

The International Air Transport Association (IATA) anticipates a landmark year for the aviation sector in 2024, projecting a record-breaking 4.7 billion passengers as the industry recovers from the Covid-19 pandemic. This forecast, announced in IATA’s annual industry trends review, signals a return to pre-pandemic growth patterns and connectivity levels. Willie Walsh, IATA’s director general, highlighted the rebound, attributing it to the public’s enduring passion for … Continue reading Aviation – Record-Breaking 4.7 Billion Passengers Expected to Fly in 2024, Surpassing Pre-Pandemic Levels